Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy. | Front Pediatr | 2022 | 36727012 | PubTator, text mining | PubMed |
| [Interpretation of the guidelines for diagnosis and treatment of mantle cell lymphoma in China (2022)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709180 | PubTator, text mining | PubMed |
| [Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709172 | PubTator, text mining | PubMed |
| [The guideline of the diagnosis and treatment of mantle cell lymphoma in China (2022)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709128 | PubTator, text mining | PubMed |
| Deciphering the mechanism of Tinospora cordifolia extract on Th17 cells through in-depth transcriptomic profiling and in silico analysis. | Front Pharmacol | 2022 | 36699055 | PubTator, text mining | PubMed |
| Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy. | Case Rep Oncol | 2022 | 36636671 | PubTator, text mining | PubMed |
| CARMA3: A potential therapeutic target in non-cancer diseases. | Front Immunol | 2022 | 36618379 | PubTator, text mining | PubMed |
| Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience. | Front Immunol | 2022 | 36605204 | PubTator, text mining | PubMed |
| Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma. | Front Oncol | 2022 | 36591517 | PubTator, text mining | PubMed |
| Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China. | Front Cell Dev Biol | 2022 | 36589752 | PubTator, text mining | PubMed |
| Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report. | BMC Neurol | 2022 | 36581860 | PubTator, text mining | PubMed |
| Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction. | Front Cell Dev Biol | 2022 | 36578789 | PubTator, text mining | PubMed |
| Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation. | Curr Res Pharmacol Drug Discov | 2022 | 36568259 | PubTator, text mining | PubMed |
| Types of T-cell lymphoma-a cytogenetic perspective. | Ann Med Surg (Lond) | 2022 | 36536747 | PubTator, text mining | PubMed |
| Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China. | BMC Med | 2022 | 36522654 | PubTator, text mining | PubMed |
| Advances in the understanding and treatment of Cutaneous T-cell Lymphoma. | Front Oncol | 2022 | 36505788 | PubTator, text mining | PubMed |
| Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. | Front Immunol | 2022 | 36505470 | PubTator, text mining | PubMed |
| Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR". | Int J Mol Sci | 2022 | 36498890 | PubTator, text mining | PubMed |
| Autoimmune Neutropenia and Immune-Dysregulation in a Patient Carrying a TINF2 Variant. | Int J Mol Sci | 2022 | 36498862 | PubTator, text mining | PubMed |
| Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers. | Cancers (Basel) | 2022 | 36497424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=20